Sanofi.Com
Bookmark
ShareSanofi.Com is a company. It is in Paris, France and it has a male CEO called Paul Hudson. It was founded in 1973 and is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Paris
- country: France
- employees: 95,442 people
- revenues: 42.2B $
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1973
- CEO: Paul Hudson
- CEO gender: male
- ESG score: Try Pro to see estimate
- environmental score (ESG): Try Pro to see estimate
- social score (ESG): Try Pro to see estimate
- governance score (ESG): Try Pro to see estimate
See more facts
Extract data
Download datasets about Sanofi.Com:
Dataset of stocks from Sanofi.Com:
Sanofi.Com is one of the companies in Pharmaceuticals, companies in Health Care, companies in Paris, companies in France and 3,456,835 companies in our database.
Talking Points
- Sanofi, an innovative global healthcare company
- We provide potentially life-changing treatments and the protection of life-saving vaccines to millions of people
- We chase the miracles of science to improve people’s lives. Interactions with this account must comply with the Terms: https://t.co/mXmuqtkblm
- We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
- A Leading Immunology Healthcare Company | Sanofi
- Sanofi pushes scientific boundaries to develop breakthrough medicines and vaccines. We chase the miracles of science to improve people’s lives.
- SANOFI ITALY: Health company, innovative and global
- Investors
- Maintaining Healthy Communities with Our Vaccines | Sanofi
- Every year, vaccination saves up to 5 million lives worldwide. Find out more about Sanofi and vaccination.
- We believe in a world where no one suffers or dies from a vaccine preventable disease. Our vaccines help protect as many as half a billion lives each year against life-threatening infectious diseases at every stage of life. With our 15000 employees worldwide, we seek to extend the protective power of vaccination to new infectious diseases while ...
- Global pharmaceutical and healthcare company Sanofi's specialty care & general medicines focus areas.
- Sanofi's global specialty care business unit focuses on rare diseases, rare blood disorders, neurology, immunology, and oncology.
- Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, rare blood disorders, neurology, immunology, and oncology
- Sanofi Genzyme is the specialty care global business unit of Sanofi. | Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, rare blood disorders, neurology, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat.
- Sanofi completes Kiadis acquisition - Sanofi
- A Sanofi Company | When it comes to life-threatening diseases, we are one family. We at Kiadis are focusing our research & development on NK cell therapeutics, leveraging the natural strengths of our immune systems to source the best cells for life. LinkedIn. Kiadis Pharma Dismiss ...
- NANOBODY® Technology Platform - Sanofi
- These tiny, modular antibodies are ushering in a new era in therapeutics at Sanofi. Here we explain how they work and why they are generating so much excitement.
- Ablynx, a Sanofi company, is engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments, which combine the advantages of conventional antibody drugs with some of the features of small-molecule drugs. Nanobodies have potential uses in the treatment of a range of serious and life-threatening human ...
